A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 236
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CCM
Long Form : cerebral cavernous malformation
No. Year Title Co-occurring Abbreviation
2020 A novel CCM3 mutation associated with cerebral cavernous malformation in a Chinese family. ---
2020 Blue Rubber Bleb Nevus Syndrome With Multiple Cavernoma-Like Lesions on MRI: A Familial Case Report and Literature Review. BRBNS, CNS, GI
2020 Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation. ---
2020 Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations. ---
2020 First interchromosomal insertion in a patient with cerebral and spinal cavernous malformations. ---
2020 KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses. MMP2, Nox1, PGE2, ROS, VEGF
2020 Predictive factors of postoperative infection-related complications in adult patients with cerebral cavernous malformations. GCS, mRS, NEU, WBC
2020 Role of aspirin and statin therapy in patients with cerebral cavernous malformations. GLMM
2020 Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. LITT
10  2020 Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study. ---
11  2019 A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis. ---
12  2019 Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening. ECs
13  2019 Blood Flow Suppresses Vascular Anomalies in a Zebrafish Model of Cerebral Cavernous Malformations. KRIT1
14  2019 Cavernous angiomas: deconstructing a neurosurgical disease. CA, CASH
15  2019 CCM1 and CCM2 variants in patients with cerebral cavernous malformation in an ethnically Chinese population in Taiwan. ---
16  2019 Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes. DEGs, GO, GO
17  2019 Could propranolol be beneficial in adult cerebral cavernous malformations? ---
18  2019 Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. MEKK3, TLR4
19  2019 Endothelial cell clonal expansion in the development of cerebral cavernous malformations. ---
20  2019 Focal epilepsy caused by single cerebral cavernous malformation (CCM) is associated with regional and global resting state functional connectivity (FC) disruption. DMN, FC, GFC, HFC, LPR, mPFC, ROIs, rs-fMRI
21  2019 KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction. ED, HAECs, ICAM-1, KRIT1, TNF-alpha, VCAM-1
22  2019 Novel Pathogenic Variants in a Cassette Exon of CCM2 in Patients With Cerebral Cavernous Malformations. ---
23  2019 Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: A decision analysis. CI, ICH, QALYs
24  2019 Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease. ---
25  2019 Two Novel CCM2 Heterozygous Mutations Associated with Cerebral Cavernous Malformation in a Chinese Family. CNS, FCCM
26  2019 Vis-a-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis. AVM, NGS
27  2019 YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM). HBMECs, RT-PCR
28  2018 A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation. FCCM, KRIT1, MRI
29  2018 A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation. ADPKD, CCM1, PC1, PC2
30  2018 A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion. ---
31  2018 Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases. ---
32  2018 Genome-Wide Sequencing Reveals Small Nucleolar RNAs Downregulated in Cerebral Cavernous Malformations. snoRNAs
33  2018 Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis. ---
34  2018 KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease. GLO1, HSPs, MG
35  2018 Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation. PtNPs, RAPA
36  2018 Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. KLF, MEKK3
37  2018 Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. QSM, SH
38  2018 Recent advances in cerebral cavernous malformation research. ---
39  2018 Surgical Management and Long-Term Seizure Outcome After Surgery for Temporal Lobe Epilepsy Associated with Cerebral Cavernous Malformations. CE, CMs, DRE, MRI, PET-CT, SS, VEEG
40  2018 Susceptibility-weighted magnetic resonance imaging of cerebrovascular sequelae after radiotherapy for pediatric brain tumors. CMB, SWI
41  2018 The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity. ---
42  2018 The STRIPAK complex components FAM40A and FAM40B regulate endothelial cell contractility via ROCKs. ---
43  2018 Two Novel KRIT1 and CCM2 Mutations in Patients Affected by Cerebral Cavernous Malformations: New Information on CCM2 Penetrance. ---
44  2018 Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease. AJs, ECs, VE
45  2018 [Microsurgical treatment of temporal cavernous malformation presenting with epilepsy]. DVAs, ECoG
46  2017 A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study. FCCM, KRIT1, MRI
47  2017 A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family. FCCM, MRI
48  2017 Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations. ICC, SWI
49  2017 Cerebral Cavernous Malformations: Patient-Reported Outcome Validates Conservative Management. EQ-5D, KPS, PRO, QOL
50  2017 Constitutional de novo and postzygotic mutations in isolated cases of cerebral cavernous malformations. ---
51  2017 Deregulated TGF-beta/BMP Signaling in Vascular Malformations. BMP, HHT, TGF
52  2017 EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation. ---
53  2017 Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition. CT, FCCMs, MR, SFCs
54  2017 Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations. miRNAs
55  2017 High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations. LR-PCR, NGS
56  2017 Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population. FCCM, KRIT1, PCR
57  2017 Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model. 4-HT, micro-CT
58  2017 Natural history of cerebral cavernous malformations. ---
59  2017 Network-based analysis of omics data: the LEAN method. LEAN, vWF
60  2017 Of Bubbles and Layers: Which Cerebral Cavernous Malformations are Most Difficult to Dissect From Surrounding Eloquent Brain Tissue? MRI
61  2017 Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation. AEDs, CRE, DS, IC, ILAE, IS
62  2017 Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging. MRI
63  2017 Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age. DVAs
64  2017 Rare case of vascular malformations in both skin and brain: Case report and published work review. VM
65  2017 Reliable? The Value of Early Postoperative Magnetic Resonance Imaging after Cerebral Cavernous Malformation Surgery. CI, MRI
66  2017 RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. ---
67  2017 Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. BMECs, TSP-1
68  2017 Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium. ROS
69  2017 Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. DCEQP, QSM
70  2017 [Gene mutations in patients with hereditary cavernous malformations]. MPLA, SNP
71  2016 Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies. CCM1
72  2016 Cerebral Cavernous Malformation: A Portuguese Family with a Novel CCM1 Mutation. ---
73  2016 Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition. ---
74  2016 Familial Multiple Cavernous Malformation Syndrome: MR Features in This Uncommon but Silent Threat. FCCM, GRE, SWI
75  2016 How Relevant Is Occlusion of Associated Developmental Venous Anomaly in Cerebral Cavernoma Surgery? A Clinical and Radiographic Comparison Study. DVA, MR
76  2016 Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results. MRT, SLA
77  2016 Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for adequate management. CT, MRI, NCC
78  2016 Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. ICH
79  2016 Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model. PtNPs, ROS
80  2016 Propranolol stops progressive multiple cerebral cavernoma in an adult patient. ---
81  2016 Role of Delta-Notch signaling in cerebral cavernous malformations. KRIT1, PDCD10, VEGF
82  2016 Two cases of familial cerebral cavernous malformation caused by mutations in the CCM1 gene. MRI
83  2015 CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation. FAT
84  2015 Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors. ICH
85  2015 Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes. Dll4
86  2015 Defective autophagy is a key feature of cerebral cavernous malformations. CCM1
87  2015 Endoport-assisted microsurgical resection of cerebral cavernous malformations. EAMR
88  2015 Expression of CCM2 and CCM3 during mouse gonadogenesis. qRT-PCR
89  2015 Genetics of cerebral cavernous malformations: current status and future prospects. ---
90  2015 Higher Rate of Intracerebral Hemorrhage in Hispanic Patients with Cerebral Cavernous Malformation. ---
91  2015 PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk. TJ
92  2015 PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations. PI3K, PTEN, VEGF
93  2015 Regulation of beta1 integrin-Klf2-mediated angiogenesis by CCM proteins. ---
94  2015 Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. ---
95  2015 Structural analysis of the KRIT1 ankyrin repeat and FERM domains reveals a conformationally stable ARD-FERM interface. ARD
96  2015 Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. ---
97  2015 Temporal lobe epilepsy and cavernous malformations: surgical strategies and long-term outcomes. ECoG, MTLE, MTS
98  2015 The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. ---
99  2015 The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3. CCM2L
100  2014 Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. CCM1, CV